Furthermore, CCR5 is shown to mobilize tumor-associated macrophages (TAM) [95], myeloid-derived suppressor cells (MDSC) [96], and regulatory T (Treg) lymphocytes [97]. This evidence concerns the gene CCR5 and neoplasm.